Advancing Stem Cell Therapy: A New Frontier in Neurological Disorder Treatment

Date: Thursday 6 Nov. 2025

Id 6
Topic Research
Speakers Xiaofeng Jia USA, Johannes Atta GERMANY, Toshiya Osanai JAPAN, Abdulrahman Shudifat JORDAN


A review of the exciting frontier of stem cell therapy for acute neurological injuries including brain injury after cardiac arrest, global anoxic injury, stroke, spinal cord injury, and peripheral nerve injury. Attendees will learn the basic science involved in stem cell procurement, generation, and differentiation. Attendees will discover the potential applications of stem cells in various acute neurological diseases such as stroke, SCI, post-cardiac arrest, and peripheral nerve injury. Attendees will investigate the limitations of translation of these stem cell therapies to clinical practice and will discuss potential solutions to this challenge.


Chair Xiaofeng Jia

11H Novel Glycoengineered human Stem Cell Therapy for Brain Injury after Cardiac Arrest. Xiaofeng Jia

11H10 New Horizon: Combine Robotics and ANOVA IRM Stem Cell-based Treatments. Johannes Atta

11H20 Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial. Toshiya Osanai

11H30 Mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study. Abdulrahman Shudifat

11H40 Free OC ID 291 The Importance of Using the Actigraph Devices to Detect the Fall Risk Among Older Adults With Sleep Disorders. Mohammed Alshehri

11H45 SUMMARY

Event Timeslots (1)

  • Oliveraie

    -

    Research



    Id 6
    Topic
    Research

    Speakers
    Xiaofeng Jia USA, Johannes Atta GERMANY, Toshiya Osanai JAPAN, Abdulrahman Shudifat JORDAN

    Chair
    Xiaofeng Jia

    11H
    Novel Glycoengineered human Stem Cell Therapy for Brain Injury after Cardiac Arrest.
    Xiaofeng Jia

    11H10
    New Horizon: Combine Robotics and ANOVA IRM Stem Cell-based Treatments.
    Johannes Atta

    11H20
    Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
    Toshiya Osanai

    11H30
    Mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study.
    Abdulrahman Shudifat

    11H40
    Free OC ID 291
    The Importance of Using the Actigraph Devices to Detect the Fall Risk Among Older Adults With Sleep Disorders.
    Mohammed Alshehri

    11H45
    SUMMARY

    ISPRM25 ISPRM25